CTTN and Parkinson disease: The results indicated that, in comparison to healthy tissues, the expression of BNIP3L and CTTN was significantly lower in PD tissues, while the expression of VPS13C and MAP1LC3B was notably higher (Wilcoxon test, P < .05).